🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

NEJM Editorial Fellow Sarah Gorey, MD (Sarah Gorey), summarizes the DapaTAVI trial.

Many LBCT’s I have seen.. NONE of them shown DON OMAR DAPA-Kuduro Song!!!! 😂😂😂 Kudos to the DAPA-TAVI team Lets make latin-music abstracts the norm 😂😂😅 Pablo Jorge Ana Viana Tejedor Carlos L. Alviar MD, FACC Soc Esp Cardiología #ACC25

Dr. Bhatt’s comment on the “DAPA-TAVI” dance was absolutely hilarious 😂🕺 nejm.org/doi/full/10.10… DapaTAVI x.com/NEJM/status/19… #ACC25 #25JCS

DapaTAVI Trial: Dapagliflozin significantly reduced mortality and heart failure worsening in high-risk older adults undergoing transcatheter aortic valve implantation (TAVI). Among patients with heart failure and additional comorbidities—such as renal insufficiency, diabetes, or

Keep up with the latest science from #ACC25 ➡️ bit.ly/4iLeXCn

Catch me blasting #DAPAKUDURO for the rest of this conference. Such a great presentation and impressive results! Another win for SGLT2i, and importantly, in the elderly population #ACC25 #DAPATAVI

What a cool end for such an awesome presentation🔥🔥 American College of Cardiology DapaTAVI Sergio Raposeiras-Roubín

David Vivas Asociación Cardiología Clínica SEC Sergio Raposeiras-Roubín Soc Esp Cardiología ResiSEC JóvenesSEC CardioRed 1 Much talento en 🇪🇸! DapaTAVI es la muestra que se pueden hacer cosas grandes con respeto, amistad y esfuerzo altruista. Grande Sergio Raposeiras-Roubín 🙌 THIS IS THE WAY

#DAPATAVI #ACC25 Among older adults with aortic stenosis undergoing TAVI who were at⬆️ risk for heart-failure, dapagliflozin resulted in a significantly lower incidence of death from any cause or worsening of heart failure than standard care alone 📎 nejm.org/doi/full/10.10…

#ACC2025 CRT Meeting TCTMD PCRonline 🫀 #DAPATAVI "Among older adults with aortic stenosis undergoing #TAVI who were at high risk for heart-failure events, dapagliflozin resulted in a significantly lower incidence of death from any cause or worsening of heart failure than

The first trial to evaluate use of an #SGLT2inhibitor in people undergoing TAVR showed benefit with dapagliflozin vs. standard care alone, including in older patients Sergio Raposeiras-Roubín @DapaTAVI #ACC25 @ACCMediaCenter American College of Cardiology healio.com/news/cardiolog…

DapaTAVI at #ACC25: 📌 The SGLT2 inhibitor #dapagliflozin was safe and effective in older adults undergoing TAVR who were at high risk for #heartfailure 📌 Genital infections, hypotension more common 📌 A “practice-changing trial” Article below #CardioTwitter @DapaTAVI

L’estudi espanyol #DapaTAVI mostra que en els pacients a qui s’ha implantat TAVI, la dapagliflozina va reduir la incidència de mort per qualsevol causa o empitjorament de la insuficiència cardíaca NEJM Sergio Raposeiras-Roubín Borja Ibanez CNIC Ander Regueiro #ACC25

🔬 Investigadores españoles del CNIC y del Hospital Universitario Álvaro Cunqueiro de Vigo demuestran que un fármaco para la #diabetes mejora el pronóstico de pacientes sometidos a intervención valvular cardiaca. 💊#Dapagliflozina redujo la tasa de muerte o de ingreso

📰 DapaTAVI 👉 SGLT2i improves outcomes after #TAVI. medpagetoday.com/meetingcoverag… | Vía MedPage Today ✍️ Crystal Phend

📢 ABRIMOS HILO 1/ La cardiología española sigue marcando hitos en la investigación. El estudio DapaTAVI , publicado en NEJM , demuestra que un fármaco para la diabetes mejora el pronóstico en pacientes con TAVI. 🫀💊👇 #DAPAKODURO

Es un placer presentar en los Podcast el DAPA-TAVI Trial DapaTAVI , presentado por el Dr. Sergio Raposeiras-Roubín . Soc Esp Cardiología ACI-SEC: Hemodinamica Cardiología Vigo Fundación EPIC ForoEpic Alfonso Jurado-Román Felipe Hernández Felipe Díez del Hoyo CACI Argentina SOLACI Felicitaciones por este trabajo

New data from @DapaTAVI in #HeartFailure2025 Soc Esp Cardiología CNIC Asociación Cardiología Clínica SEC Cardiología Vigo INCLIVA Sergio Raposeiras-Roubín Borja Ibanez Xavier Rosselló Ignacio J. Amat Clara Bonanad Rafael González Manzanares Vamossss

🔥#HeartFailure2025 #LBCT #DapaTAVI Quality of Life #SGLT2i dapa in severe AS undergoing TAVI Main paper NEJM ↓ deaths & worsening HF: nejm.org/doi/full/10.10… New LBCT Clara Bonanad curiously no incremental gains in QOL Great reporting by Todd Neale: tctmd.com/news/no-additi…

NEJM Sergio Raposeiras-Roubín CNIC DapaTAVI Ander Regueiro Hospital Clínic 🆕Un estudio publicado en NEJM donde ha participado el #CLÍNIC-#IDIBAPS demuestra que un fármaco para la diabetes mejora el pronóstico de pacientes sometidos a intervención valvular cardiaca percutánea 👉f.mtr.cool/gvcsbpkosf